Positive Study Results Published for KidneyIntelX™ in Monitoring Patient Response to New Drug Therapy
January 11, 2022 08:15 ET
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Renalytix (NASDAQ: RNLX) (LSE: RENX) announced the publication of positive study results for KidneyIntelX™ as a risk monitoring tool to...
Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast
January 10, 2022 07:00 ET
|
Renalytix plc
GULF COAST, Miss. and SALT LAKE CITY, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singing River Health System and Renalytix (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to deploy KidneyIntelX™...
Renalytix Appoints Jean M. Casner as Chief Human Resources Officer
January 07, 2022 07:00 ET
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M. Casner joined the Company this week on January 3, 2022 as Senior...
Renalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference
January 05, 2022 07:00 ET
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the Company will be presenting at the upcoming...
American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population
January 04, 2022 07:00 ET
|
Renalytix plc
ARLINGTON, Va. and SALT LAKE CITY, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The American Diabetes Association® (ADA) and Renalytix (NASDAQ: RNLX) (LSE: RENX) announced today a joint program to improve...
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
December 07, 2021 07:02 ET
|
Renalytix plc
NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing...
Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7
December 02, 2021 07:00 ET
|
Renalytix
NEW YORK and SALT LAKE CITY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will release first quarter fiscal year 2022 financial results on...
Renalytix Convenes Expert Panel at VA Healthcare Summit
November 10, 2021 07:00 ET
|
Renalytix
NEW YORK and SALT LAKE CITY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- In recognition of National Diabetes Month and concurrent with the launch of KidneyIntelX in the Veterans Health Administration health...
St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York
November 09, 2021 07:00 ET
|
Renalytix
NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- St. Joseph's Health and Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to implement an advanced clinical care model designed to...
Renalytix Reports Full Year Fiscal 2021 Results
October 21, 2021 07:00 ET
|
Renalytix
LONDON and SALT LAKE CITY, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical...